Kinaxis (TSE:KXS) had its price objective lifted by Canaccord Genuity from C$90.00 to C$92.00 in a report published on Friday, BayStreet.CA reports.
Separately, Royal Bank of Canada raised their price target on shares of Kinaxis from C$90.00 to C$95.00 and gave the company an outperform rating in a research report on Monday, May 13th.
TSE KXS traded down C$1.17 during trading hours on Friday, hitting C$82.36. The company’s stock had a trading volume of 191,600 shares, compared to its average volume of 92,115. Kinaxis has a 52 week low of C$60.01 and a 52 week high of C$100.68. The stock has a market capitalization of $2.15 billion and a P/E ratio of 130.73. The company has a debt-to-equity ratio of 5.99, a current ratio of 2.73 and a quick ratio of 2.65. The company’s 50-day moving average price is C$82.10.
In other Kinaxis news, Senior Officer Richard George Monkman sold 3,000 shares of Kinaxis stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of C$83.71, for a total transaction of C$251,130.00. Also, Director John Ernest Sicard sold 1,900 shares of Kinaxis stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of C$80.00, for a total transaction of C$152,000.00. Following the transaction, the director now directly owns 48,989 shares in the company, valued at approximately C$3,919,120. In the last three months, insiders have sold 11,100 shares of company stock worth $880,723.
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. The company offers RapidResponse, which provide supply chain planning and analytics capabilities for managing various supply chain management processes, including demand planning, supply planning, inventory management, order fulfillment, capacity planning, and master scheduling, as well as sales and operations planning process.
Featured Article: Cost of Goods Sold (COGS)
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.